[Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders]

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(6):93-100.
[Article in Russian]

Abstract

The literature review contains data about functions of glycogen synthase kinase-313 (GSK-313) in the cell and its role in the functioning of the nervous tissue, an analysis of current research on the participation of GSK-313 in the pathogenesis of affective disorders and schizophrenia and effect of psychotropic drugs on the activity of the kinase.

Publication types

  • Review

MeSH terms

  • Glycogen Synthase Kinase 3 / genetics
  • Glycogen Synthase Kinase 3 / metabolism*
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Molecular Targeted Therapy
  • Mood Disorders / drug therapy
  • Mood Disorders / enzymology*
  • Mood Disorders / genetics
  • Polymorphism, Genetic
  • Psychotropic Drugs / pharmacology
  • Psychotropic Drugs / therapeutic use
  • Schizophrenia / drug therapy
  • Schizophrenia / enzymology*
  • Schizophrenia / genetics

Substances

  • Psychotropic Drugs
  • GSK3B protein, human
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3